Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software
08. März 2022 09:30 ET
|
Inspirata, Inc.
Tampa, Florida, March 08, 2022 (GLOBE NEWSWIRE) -- Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance...
NIH/NCI Grants Awarded to Inspirata and Case Western Reserve University Projects to Investigate Whole Slide Image Analysis to Predict the Aggressiveness of Certain Cancers
20. März 2018 06:00 ET
|
Inspirata, Inc.
Vancouver, BC, March 20, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has been awarded a new National...
Inspirata’s Digital Pathology Solution Supports 1st Digital Primary Diagnosis in U.S.
19. März 2018 06:00 ET
|
Inspirata, Inc.
Vancouver, BC, March 19, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that its workflow solution-as-a-service...